OFIDโs Case of the Month for April discusses an unusual case of multiclass transmitted drug resistance successfully treated with DTG plus tenofovir alafenamide and emtricitabine.
๐:https://t.co/eEc2pU6hKn #OpenForumInfectDis@PaulSaxMD@DrJLi@EllenNagami @KinnaThakarar
@PaulSaxMD @swinndong @eeeejjjaaaa This is great. Iโm so glad patient dignity is addressed. Looking forward to reading this article written by a few my faves: @WendyStead5 @swinndong @eeeejjjaaaa
Today we approved the first injectable treatment for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prevention to reduce the risk of sexually acquired HIV. https://t.co/TBU7pU6gOo
The "History of HIV" talk I gave last week actually has this title, which I don't think is an overstatement. Posting it now with gratitude, just in time for Thanksgiving (my favorite holiday -- the gratitude and family part).
(Part 1 thread)
1/x
The "History of HIV" talk I gave last week actually has this title, which I don't think is an overstatement. Posting it now with gratitude, just in time for Thanksgiving (my favorite holiday -- the gratitude and family part).
(Part 1 thread)
1/x
Government service was never part of my plans. But every doctor knows that when a patient is coding, your plans donโt matter. You run to the code.
And when a nation is codingโif you are called to serve, you serve.